No Detail Found!

Frequency of Primary Hyperaldosteronism in Young Hypertensives in a Tertiary Care Setting of Rawalpindi.

Author(s)
Mehwish Gilani Department of Chemical Pathology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Naveed Asif Department of Chemical Pathology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Asif Nawaz Department of Chemical Pathology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Ammad Akram Department of Medicine, Military Hospital, Rawalpindi, Pakistan
Abstract
Objective: To determine the frequency of primary hyperaldosteronism in young hypertensives in hospital settings of Rawalpindi. Study Design: Cross-sectional study. Place and Duration of Study: Department of Chemical Pathology and Endocrinology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, from June 2016 to May 2017. Methodology: Two hundred and fifty patients with hypertension (blood pressure of more than 140/90 mm Hg) of both genders, with age between 17-40 years were recruited in the study. Patients on anti-hypertensive medications, renal function derangement, pregnant females and those labelled with secondary hypertension were excluded. Blood samples were taken for the analyses of plasma renin, aldosterone, electrolytes, and blood gases. Parametric quantitative variables were presented as mean + SD. Results: Eight cases, out of a total 80 subjects fulfilling the inclusion criteria, were diagnosed with primary hyperaldosteronism and 72 with essential hypertension. Mean age of patients having primary hyperaldosteronism was 29.25 +7.1 years. The mean diastolic blood pressure of all patients was 90.3 +6.5 mm of Hg, while mean systolic blood pressure was 142.7 +10.5 mm of Hg. Conclusion: Frequency of primary hyperaldosteronism was found to be 10%, emphasising on the fact that it is not very uncommon in young hypertensives.
Publication Details
Page(s) 58-61
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 29, Issue: 1, Year: 2019

Request the full text from PASTIC

References
ShrivastavaSR,ShrivastavaPS,RamasamyJ., 2014.The determinants and scope of public health interventions to tackle the global problem of hypertension,Int J Prev Med 5 807 -
SarafidisPA,LiS,ChenSC,CollinsAJ,BrownWW,KlagMJ, 2008.Hypertension awareness, treatment, and control in chronic kidney disease,Am J Med 121 332 -40
MohanS,CampbellNR, 2009.Hypertension management: time to shift gears and scale up national efforts,Hypertension 53 450 -1
JohnsonHM,ThorpeCT,BartelsCM,SchumacherJR,PaltaM,PandhiN, 2014.Undiagnosed hypertension among young adults with regular primary care use,J Hypertens 32 65 -74
SaleemF,HassaliAA,ShafieAA, 2010.Hypertension in Pakistan: time to take some serious action,Br J Gen Pract 60 449 -50
BavishiC,BangaloreS,MesserliFH, 2016.Renin angiotensin aldosterone system inhibitors in hypertension: Is there evidence for benefit independent of blood pressure reduction?,Prog Cardiovasc Dis 59 253 -61
ThethiT,KamiyamaM,KoboriH., 2012.The link between the reninangiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome,Cur Hypertens Rep 14 160 -9
ChoiM,SchollUI,YueP,BjörklundP,ZhaoB,Nelson-WilliamsC, 2011.K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension,Science 331 768 -72
MaTK,KamKK,YanBP,LamYY, 2010.Renin-angiotensinaldosterone system blockade for cardiovascular diseases: current status,Br J Pharmacol 160 1273 -92
TsiavosV,MarkouA,PapanastasiouL,KounadiT,AndroulakisII,VoulgarisN, 2016.A new highly sensitive and specific overnight combined screening and diagnostic test for primary aldosteronism,Eur J Endocrinol 175 21 -8
ArdhanariS,KannuswamyR,ChaudharyK,LocketteW,Whaley-ConnellA, 2015.Mineralocorticoid and apparent mineralocorticoid syndromes of secondary hypertension,Adv Chronic Kidney Dis 22 185 -95
WangLP,YangKQ,JiangXJ,WuHY,ZhangHM,ZouYB, 2015.Prevalence of Liddle syndrome among young hypertension patients of undetermined cause in a Chinese population,J Clin Hypertens 17 902 -7
GloverM,WareJS,HenryA,WolleyM,WalshR,WainLV, 2014.Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon's syndrome),Clin Sci 126 721 -6
RossiGP,BerniniG,CaliumiC,DesideriG,FabrisB,FerriC, 2006.A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients,J Am Coll Cardiol 48 2293 -300
LohKC,KoayES,KhawMC,EmmanuelSC, 2000.Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore,J Clin Endocrinol Metab 85 2854 -9
PerschelFH,SchemerR,SeilerL,ReinckeM,DeinumJ,Maser-GluthC, .Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin, -
PourhoseingholiMA,VahediM,RahimzadehM., 2013.Sample size calculation in medical studies,Gastroenterol Hepatol Bed Bench 6 14 -
SchollUI,HealyJM,ThielA,FonsecaAL,BrownTC,KunstmanJW, 2015.Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype,Clin Endocrinol 83 779 -89
DoumaS,PetidisK,DoumasM,PapaefthimiouP,TriantafyllouA,KartaliN, 2008.Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study,Lancet 371 1921 -6
FogariR,PretiP,ZoppiA,RinaldiA,FogariE,MugelliniA, 2007.Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test,Hypertens Res 30 111 -7
KebebewE., 2018.Ethnic specific differences in endocrine neoplasms: The role of susceptibility genes,Am J Surg 215 1060 -1
0

Citations

0

Downloads

75

Views